Publications de Patrycja Nowak-Sliwinska

Towards Light-Activated Ruthenium-Arene (RAPTA-Type) Prodrug Candidates

Rosario Scopelliti, Paul Joseph Dyson, Patrycja Nowak-Sliwinska, Anna Katherine Renfrew, Felix Daniel Bobbink

Cancer is currently one of the deadliest diseases worldwide. Based on the high incidence of this disease, the side effects associated with current chemotherapies and the appearance of drug resistance, considerable efforts have been directed towards the dev ...

WILEY-V C H VERLAG GMBH2019

Helical equilibrium magnetohydrodynamic flow effects on the stability properties of low-n ideal external-infernal modes in weak shear tokamak configurations

Wilfred Anthony Cooper, Jonathan Graves, Patrycja Nowak-Sliwinska, Daniele Brunetti, Alberto Mariani

The impact of equilibrium helical flows on the stability properties of low shear tokamak plasmas is assessed. The corrections due to such helical flow to the equilibrium profiles (mass density, pressure, Shafranov shift, magnetic fluxes) are computed by mi ...

IOP PUBLISHING LTD2019

Recent Considerations in the Application of RAPTA-C for Cancer Treatment and Perspectives for Its Combination with Immunotherapies

Paul Joseph Dyson, Patrycja Nowak-Sliwinska, Magdalena Rausch

The organometallic ruthenium(II) [Ru(arene)Cl2PTA] PTA - 1,3,5-triaza-7-phosphaadamantane compound, RAPTA-C, represents an innovative anti-cancer therapeutic and a better-tolerated alternative to platinum (Pt)-based chemotherapeutic drugs in the treatment ...

WILEY2019

Validation of the ICRF antenna coupling code RAPLICASOL against TOPICA and experiments

Patrick Blanchard, Roland Behn, Basil Duval, Timothy Goodman, Pierre Jacquot, Bruno Marchand, Yves Martin, Pascal Morel, Jean-Marc Moret, Richard Pitts, Olivier Sauter, Holger Reimerdes, Stefano Coda, Alberto Bottino, Marco Wischmeier, Jan Horacek, Andrea Scarabosio, Hartmut Zohm, Alexander Karpushov, Laurie Porte, Yanis Andrebe, Yann Camenen, Thomas Binderup Jensen, Duccio Testa, Telmo David Ribeiro Da Costa, Benoît Labit, Emiliano Fable, Patrycja Nowak-Sliwinska, Javier García Hernández, Ben McMillan, Marc Gruber, Christian Gabriel Theiler, Federico Alberto Alfredo Felici, Jose Felix Vega Stavro, Lenke Horváth, Dávid Wágner, Attila Bencze, Thomas Riedl, Lorenzo Anton-Louis Talà, Diego Carnevale, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Development of an Efficient Dual-Action GST-Inhibiting Anticancer Platinum(IV) Prodrug

Paul Joseph Dyson, Wee Han Ang, Patrycja Nowak-Sliwinska

The cytotoxicity of cisplatin (cDDP) is enhanced when co-administered with ethacrynic acid (EA), a glutathione S-transferase (GST) inhibito r. A Pt-lV EA conjugate containing a cDDP core and two axial ethacrynate ligands (compound 1) was shown to be an ex ...

2018

Consensus guidelines for the use and interpretation of angiogenesis assays

Patrycja Nowak-Sliwinska, Elizabeth Anne Allen, Michele De Palma, George Coukos, Yan Gong

The formation of new blood vessels, or angiogenesis, is a complex process that plays important roles in growth and development, tissue and organ regeneration, as well as numerous pathological conditions. Angiogenesis undergoes multiple discrete steps that ...

2018

Current Trends in Multidrug Optimization: An Alley of Future Successful Treatment of Complex Disorders

Patrycja Nowak-Sliwinska

The identification of effective and long-lasting cancer therapies still remains elusive, partially due to patient and tumor heterogeneity, acquired drug resistance, and single-drug dose-limiting toxicities. The use of drug combinations may help to overcome ...

Sage Publications Inc2017

Combination of ruthenium(II)-arene complex [Ru(eta(6)-p-cymene)Cl-2(pta)] (RAPTA-C) and the epidermal growth factor receptor inhibitor erlotinib results in efficient angiostatic and antitumor activity

Paul Joseph Dyson, Patrycja Nowak-Sliwinska, Patrick Meraldi, Ume-Gulsoom Abdul

Ruthenium-based compounds show strong potential as anti-cancer drugs and are being investigated as alternatives to other well-established metal-based chemotherapeutics. The organometallic compound [Ru(eta(6)-p-cymene) Cl-2(pta)], where pta = 1,3,5-triaza-7 ...

Nature Research2017

Epigenetic approach for angiostatic therapy: promising combinations for cancer treatment

Paul Joseph Dyson, Patrycja Nowak-Sliwinska, Marije Trudi Te Winkel, Ume-Gulsoom Abdul

Cancer cells are often dependent on epigenetic pathways for their survival. Consequently, drugs that target the epigenome, rather than the underlying DNA sequence, are currently attracting considerable attention. In recent years, the first epigenetic drugs ...

Springer Verlag2017

Drug Combination for Treatment of Proliferative Diseases

Hubert van den Bergh, Paul Joseph Dyson, Patrycja Nowak-Sliwinska

Angiogenesis inhibitory drug combination obtained according to a specific algorithm, preferably a FSC, in which an initial combination of drugs is iteratively adjusted. The drug combination according to the invention may advantageously comprise a RAPTA-C c ...

2017

Anti-angiogenic properties of chlorambucil derivatives with fluorous and hydrocarbon appendages

Paul Joseph Dyson, Patrycja Nowak-Sliwinska, Catherine Marie Amélie Clavel, Emilia Paunescu

Chlorambucil (CLB) derivatives with long fluorous (referred to as 1 and 2) or hydrocarbon (3) chains have been evaluated in a series of in vitro and in vivo assays. In cell viability inhibition assays, both derivatives 2 and 3 show selective cytotoxicity t ...

Royal Society of Chemistry2016

Optimization of drug combinations using Feedback System Control

Hubert van den Bergh, Paul Joseph Dyson, Patrycja Nowak-Sliwinska

We describe a protocol for the discovery of synergistic drug combinations for the treatment of disease. Synergistic drug combinations lead to the use of drugs at lower doses, which reduces side effects and can potentially lead to reduced drug resistance, w ...

Nature Publishing Group2016

Chlorambucil conjugates of dinuclear p-cymene ruthenium trithiolato complexes: synthesis, characterization and cytotoxicity study in vitro and in vivo

Paul Joseph Dyson, Patrycja Nowak-Sliwinska

Four diruthenium trithiolato chlorambucil conjugates have been prepared via Steglich esterification from chlorambucil and the corresponding trithiolato precursors. All conjugates are highly cytotoxic towards human ovarian A2780 and A2780cisR cancer cell li ...

Springer Verlag2016

Photoactivation of lysosomally sequestered sunitinib after angiostatic treatment causes vascular occlusion and enhances tumor growth inhibition

Hubert van den Bergh, Patrycja Nowak-Sliwinska

The angiogenesis inhibitor sunitinib is a tyrosine kinase inhibitor that acts mainly on the VEGF and PDGF pathways. We have previously shown that sunitinib is sequestered in the lysosomes of exposed tumor and endothelial cells. This phenomenon is part of t ...

Nature Publishing Group2015

Antiangiogenic and Anticancer Properties of Bifunctional Ruthenium(II)-p-Cymene Complexes: Influence of Pendant Perfluorous Chains

Paul Joseph Dyson, Patrycja Nowak-Sliwinska, Catherine Marie Amélie Clavel, Emilia Paunescu, Marije Trudi Te Winkel

Two bifunctional ruthenium(II)-p-cymene complexes with perfluorinated side chains, attached via pyridine ligands, have been evaluated in a series of in vitro and in vivo assays. Their effects on human endothelial (ECRF24 and HUVEC) cells, noncancerous huma ...

Amer Chemical Soc2015

Anticancer Organometallic Osmium(II)-p-cymene Complexes

Rosario Scopelliti, Paul Joseph Dyson, Patrycja Nowak-Sliwinska, Catherine Marie Amélie Clavel, Emilia Paunescu

Osmium compounds are attracting increasing attention as potential anticancer drugs. In this context, a series of bifunctional organometallic osmium(II)-p-cymene complexes functionalized with alkyl or perfluoroalkyl groups were prepared and screened for the ...

Wiley-V C H Verlag Gmbh2015

Finding The Optimal Balance: Vascular Modulation Prior To Chemo- Or Photodynamic Therapy In Cancer Treatment

Patrycja Nowak-Sliwinska

Karger2015

Improved Angiostatic Activity of Dasatinib by Modulation with Hydrophobic Chains

Paul Joseph Dyson, Patrycja Nowak-Sliwinska, Catherine Marie Amélie Clavel, Emilia Paunescu

Dasatinib is an orally active nonselective tyrosine kinase inhibitor used to treat certain types of adult leukemia. By inhibiting PDGFR-beta and SFKs in both tumor cells and tumor associated endothelial cells, dasatinib inhibits tumor growth and angiogenes ...

Amer Chemical Soc2015

In vivo evaluation of small-molecule thermoresponsive anticancer drugs potentiated by hyperthermia

Paul Joseph Dyson, Patrycja Nowak-Sliwinska, Catherine Marie Amélie Clavel, Emilia Paunescu

Hyperthermia used as an adjuvant with chemotherapy is highly promising in the treatment of certain cancers. Currently, the small molecule drugs used in combination with hyperthermia were not designed for this application. Herein, we report the evaluation o ...

2015

Insulin Receptor Marks The Tumor Endothelium; Its Role During Tumor Angiogenesis And Angiostatic Treatment

Patrycja Nowak-Sliwinska

Karger2015